Hyundai Halts Advertising on X Amid Antisemitism Row 
Lotte Wellfood Brings Its Pepero Products to Thailand’s King Power Duty-Free Shop 
Meta AI to Supercharge WhatsApp, Facebook, Instagram via Powerful Integration 
PUMA and BMW MMS Launch Vibrant Crews Go Summer Collection 
Google Fired Workers Protesting Over Cloud Contract Deal With Israel 
Coca-Cola Launches Global 'Recycle Me' Campaign to Champion Recycling 
Adidas Unveils Innovative Team Kits for Paris 2024 Olympics and Paralympics 
Samsung Implements Emergency 6-Day Work Week to Combat Slowing Growth 
Canada Set to Enforce OECD Crypto Tax Standards by 2026 
SPC Group’s Paris Baguette Inaugurates First Bakery Shop in the Philippines 
Taeyoung to Sack Executives, Cut Employees' Salaries to Save Company 
Nissan Cuts Profit Forecasts Amidst Sales Slump and Natural Disaster 
Samsung's Exynos 2500 Rumored to Eclipse Snapdragon 8 Gen 4 in Power Efficiency With 3nm SoC 
Mister Donut and Gion Tsujiri Unite Once More for Kyoto-Inspired Donut Delights 
Huawei Unveils Pura 70 Series to Rival Apple's Dominance in China's Smartphone Arena 
LVMH Adds Bernard Aranault’s Sons Frederic and Alexandre Arnault to the Board 
Adidas Ignites Passion with 2024 Athlete Pack Including 49 Footwear Models 
DUBLIN, Ireland, May 26, 2017 -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will participate at the following conferences in June:
Jefferies 2017 Global Healthcare Conference
- Date: June 6, 2017
- Presentation Time: 11:30 a.m. ET
- Location: New York, NY
The JMP Securities Life Science Conference
- Presentation Date: June 21, 2017
- Presentation Time: 1:30 p.m. ET
- Location: New York, NY
The conferences presentations will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.
About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets 11 medicines through its orphan, rheumatology and primary care business units. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.
Contacts:
| Investors: | U.S. Media: |
| Tina Ventura | Geoff Curtis |
| Senior Vice President, | Senior Vice President, |
| Investor Relations | Corporate Affairs & Chief Communications Officer |
| [email protected] | [email protected] |
| Ruth Venning | Ireland Media: |
| Executive Director, | Ray Gordon |
| Investor Relations | Gordon MRM |
| [email protected] | [email protected] |
